Dallah Healthcare Company

SR 58.75As of Sun 8 Nov 2026, 12:00 UTC
Tadawul:4004Healthcare
Country Saudi Arabia
PE (Fwd) •••
TSR 10Y CAGR 4.46%
Div yield 3.40%
ROE 10.31%
Medical Care Facilities
Beta (5Y) (0.38)
PE TTM 16.23
TSR TTM (53.43%)
Mkt cap SR 7.106B
ROIC 6.26%
SE Grade™
Value
Quality
Moat
Consensus
Reference
SR 76
29.31%
(70.99%)
Hold 8|10|1|0|12
4Q25
1Q26
2Q26
3Q26
Earnings per shareSR
1.21
1.27
1.23
1.17
17.33%
19.88%
10.26%
(3.99%)
RevenueSR M
441.9
468.2
471.4
468.3
21.78%
23.15%
17.06%
11.62%
Peers (US$1.954B)
Cap (US$)
PE
1.920B
30.07x
1.291B
28.74x
Capital
TTM
5Y
10Y
Leveragex
1.175
(0.305)
(0.311)
EBIT/Intx
0.759
0.219
0.167
Own earn%
116.54
(48.60)
(46.80)
Sh yield%
28.78
25.64
32.75
Owners
Insiders/Inst%
14.30
50.87
Short interest%
1.01
SBC / revenue%
4.45
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
2
Op margin range%
11–21
$1 testx
—
Incr. ROIC%
6